Indo-Bangla Pharmaceuticals (DHA:IBP) OCF Yield %: 0.00 (As of Jun. 28, 2026)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT15.30
View Full Analysis

What is Indo-Bangla Pharmaceuticals OCF Yield %?

Indo-Bangla Pharmaceuticals DHA:IBP +1.32% 32 OCF Yield % is 0.00 as of Jun. 28, 2026. GuruFocus rates DHA:IBP with a GF Score™ of 32/100. Among 1,005 Drug Manufacturers companies, Indo-Bangla Pharmaceuticals ranks worse than 99502.39% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Indo-Bangla Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is BDT0.00 Mil, and Market Cap is BDT0.00 Mil. Therefore, Indo-Bangla Pharmaceuticals's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Indo-Bangla Pharmaceuticals's OCF Yield % or its related term are showing as below:


DHA:IBP's OCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.61
* Ranked among companies with meaningful OCF Yield % only.

Indo-Bangla Pharmaceuticals's OCF Margin % for the quarter that ended in . 20 was %.

Indo-Bangla Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Indo-Bangla Pharmaceuticals OCF Yield % Related Terms

Indo-Bangla Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals OCF Yield % Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
OCF Yield %

Indo-Bangla Pharmaceuticals Semi-Annual Data
OCF Yield %
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Indo-Bangla Pharmaceuticals's OCF Yield % for the fiscal year that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
= /
=N/A%

Indo-Bangla Pharmaceuticals's annualized OCF Yield % for the quarter that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
= * 1 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a OCF Yield % of 0.00 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Indo-Bangla Pharmaceuticals and its competitors. According to the industry distribution chart, Indo-Bangla Pharmaceuticals ranks #999999 out of 1005 companies in the Drug Manufacturers industry.
Is Indo-Bangla Pharmaceuticals' OCF Yield % too high?
Indo-Bangla Pharmaceuticals' current OCF Yield % is 0.00. Based on the distribution chart, Indo-Bangla Pharmaceuticals ranks #999999 out of 1005 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' OCF Yield % compare to ?
According to the Drug Manufacturers industry distribution chart, Indo-Bangla Pharmaceuticals ranks #999999 out of 1005 companies for OCF Yield %. This places Indo-Bangla Pharmaceuticals in the lower half of its industry. The industry median OCF Yield % is 3.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Indo-Bangla Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo-Bangla Pharmaceuticals's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current OCF Yield % is 0.00 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.30
Price